A soluble variant of CD163 (sCD163), a product of shedding, is present in plasma and other tissue fluids [13] and has been found to be increased in various solid tumors and hematological malignancies, reflecting the increased burden of TAMs overexpressing CD163 [15]. The gene discussed is CD163; the disease is hematologic disorder.